GlaxoSmithKline CEO Andrew Witty's proposal for companies to pool their patents to develop medicines for neglected tropical diseases is a somewhat unusual call for collaboration in the pharmaceutical industry, but not entirely without precedent
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
